Cellectar's Series C Round

Cellectar raised a round of funding on January 10, 2008.

Cellectar is a radiopharmaceuticals company that designs, develops, and manufactures products to detect, treat and monitor a wide variety of human cancers. Their product candidates combine lipid-like …

Articles about Cellectar's Series C Round: